Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus

Leland J. Yee, Yong Ming Tang, David E. Kleiner, Dai Wang, KyungAh Im, Abdus Wahed, Xiaomei Tong, Shannon Rhodes, Xiaowen Su, R. Margaret Whelan, Robert J. Fontana, Marc G. Ghany, Brian Borg, T. Jake Liang, Huiying Yang

Research output: Contribution to journalArticle

Abstract

Candidate genes, including myxovirus resistance-1 (Mx1), protein kinase (PKR), transforming growth factor-β1 (TGF-β), interleukin-10 (IL-10), and interferon-gamma (IFN-γ), were evaluated for associations with liver fibrosis in 374 treatment-naive patients with genotype-1 chronic HCV infection [194 Caucasian Americans (CAs) and 180 African Americans (AAs)], using a genetic haplotype approach. Among the 18 haplotypes that occurred with a frequency ≥5% in the cohort overall, the Mx1-(-123C)-(+6886A)-(+19820G(379V))-(+38645T) (abbreviated Mx1-CAGT), and PKR-(+110T)-(+7949G)-(+13846A)-(+22937Tj-(+40342T) (abbreviated PKR-TGATT) haplotypes were independently associated with less severe hepatic fibrosis (Ishak ≥ 3 versus s) = 0.6)], and race (for Mx1-CAGT: OR = 0.33; 95% CI: 0.16-0.68; P = 0.0027; and for PKR-TGATT: OR = 0.56; 95% CI: 0.32-0.98; P = 0.0405). Population structure was evaluated using the structured association method using data from 161 ancestry-informative markers and did not affect our findings. We used an independent cohort of 34 AA and 160 CA in an attempt to validate our findings, although notable differences were found in the characteristics of the two patient groups. Although we observed a similar protective trend for the Mx1-CAGT haplotype in the validation set, the association was not statistically significant. Conclusion: In addition to other factors, polymorphisms in cytokine genes may play a role in the progression of HCV-related fibrosis; however, further studies are needed.

Original languageEnglish (US)
Pages (from-to)74-83
Number of pages10
JournalHepatology
Volume46
Issue number1
DOIs
StatePublished - Jul 2007
Externally publishedYes

Fingerprint

Chronic Hepatitis C
Orthomyxoviridae
Hepacivirus
Protein Kinases
Haplotypes
Fibrosis
African Americans
Myxovirus Resistance Proteins
eIF-2 Kinase
Transforming Growth Factors
Liver Cirrhosis
Interleukin-10
Genes
Interferon-gamma
Genotype
Cytokines
Liver
Infection
Population
Therapeutics

ASJC Scopus subject areas

  • Hepatology

Cite this

Yee, L. J., Tang, Y. M., Kleiner, D. E., Wang, D., Im, K., Wahed, A., ... Yang, H. (2007). Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. Hepatology, 46(1), 74-83. https://doi.org/10.1002/hep.21636

Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. / Yee, Leland J.; Tang, Yong Ming; Kleiner, David E.; Wang, Dai; Im, KyungAh; Wahed, Abdus; Tong, Xiaomei; Rhodes, Shannon; Su, Xiaowen; Whelan, R. Margaret; Fontana, Robert J.; Ghany, Marc G.; Borg, Brian; Liang, T. Jake; Yang, Huiying.

In: Hepatology, Vol. 46, No. 1, 07.2007, p. 74-83.

Research output: Contribution to journalArticle

Yee, LJ, Tang, YM, Kleiner, DE, Wang, D, Im, K, Wahed, A, Tong, X, Rhodes, S, Su, X, Whelan, RM, Fontana, RJ, Ghany, MG, Borg, B, Liang, TJ & Yang, H 2007, 'Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus', Hepatology, vol. 46, no. 1, pp. 74-83. https://doi.org/10.1002/hep.21636
Yee LJ, Tang YM, Kleiner DE, Wang D, Im K, Wahed A et al. Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. Hepatology. 2007 Jul;46(1):74-83. https://doi.org/10.1002/hep.21636
Yee, Leland J. ; Tang, Yong Ming ; Kleiner, David E. ; Wang, Dai ; Im, KyungAh ; Wahed, Abdus ; Tong, Xiaomei ; Rhodes, Shannon ; Su, Xiaowen ; Whelan, R. Margaret ; Fontana, Robert J. ; Ghany, Marc G. ; Borg, Brian ; Liang, T. Jake ; Yang, Huiying. / Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. In: Hepatology. 2007 ; Vol. 46, No. 1. pp. 74-83.
@article{c64ab12f1b594b069ef7925a9bd5535a,
title = "Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus",
abstract = "Candidate genes, including myxovirus resistance-1 (Mx1), protein kinase (PKR), transforming growth factor-β1 (TGF-β), interleukin-10 (IL-10), and interferon-gamma (IFN-γ), were evaluated for associations with liver fibrosis in 374 treatment-naive patients with genotype-1 chronic HCV infection [194 Caucasian Americans (CAs) and 180 African Americans (AAs)], using a genetic haplotype approach. Among the 18 haplotypes that occurred with a frequency ≥5{\%} in the cohort overall, the Mx1-(-123C)-(+6886A)-(+19820G(379V))-(+38645T) (abbreviated Mx1-CAGT), and PKR-(+110T)-(+7949G)-(+13846A)-(+22937Tj-(+40342T) (abbreviated PKR-TGATT) haplotypes were independently associated with less severe hepatic fibrosis (Ishak ≥ 3 versus s) = 0.6)], and race (for Mx1-CAGT: OR = 0.33; 95{\%} CI: 0.16-0.68; P = 0.0027; and for PKR-TGATT: OR = 0.56; 95{\%} CI: 0.32-0.98; P = 0.0405). Population structure was evaluated using the structured association method using data from 161 ancestry-informative markers and did not affect our findings. We used an independent cohort of 34 AA and 160 CA in an attempt to validate our findings, although notable differences were found in the characteristics of the two patient groups. Although we observed a similar protective trend for the Mx1-CAGT haplotype in the validation set, the association was not statistically significant. Conclusion: In addition to other factors, polymorphisms in cytokine genes may play a role in the progression of HCV-related fibrosis; however, further studies are needed.",
author = "Yee, {Leland J.} and Tang, {Yong Ming} and Kleiner, {David E.} and Dai Wang and KyungAh Im and Abdus Wahed and Xiaomei Tong and Shannon Rhodes and Xiaowen Su and Whelan, {R. Margaret} and Fontana, {Robert J.} and Ghany, {Marc G.} and Brian Borg and Liang, {T. Jake} and Huiying Yang",
year = "2007",
month = "7",
doi = "10.1002/hep.21636",
language = "English (US)",
volume = "46",
pages = "74--83",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus

AU - Yee, Leland J.

AU - Tang, Yong Ming

AU - Kleiner, David E.

AU - Wang, Dai

AU - Im, KyungAh

AU - Wahed, Abdus

AU - Tong, Xiaomei

AU - Rhodes, Shannon

AU - Su, Xiaowen

AU - Whelan, R. Margaret

AU - Fontana, Robert J.

AU - Ghany, Marc G.

AU - Borg, Brian

AU - Liang, T. Jake

AU - Yang, Huiying

PY - 2007/7

Y1 - 2007/7

N2 - Candidate genes, including myxovirus resistance-1 (Mx1), protein kinase (PKR), transforming growth factor-β1 (TGF-β), interleukin-10 (IL-10), and interferon-gamma (IFN-γ), were evaluated for associations with liver fibrosis in 374 treatment-naive patients with genotype-1 chronic HCV infection [194 Caucasian Americans (CAs) and 180 African Americans (AAs)], using a genetic haplotype approach. Among the 18 haplotypes that occurred with a frequency ≥5% in the cohort overall, the Mx1-(-123C)-(+6886A)-(+19820G(379V))-(+38645T) (abbreviated Mx1-CAGT), and PKR-(+110T)-(+7949G)-(+13846A)-(+22937Tj-(+40342T) (abbreviated PKR-TGATT) haplotypes were independently associated with less severe hepatic fibrosis (Ishak ≥ 3 versus s) = 0.6)], and race (for Mx1-CAGT: OR = 0.33; 95% CI: 0.16-0.68; P = 0.0027; and for PKR-TGATT: OR = 0.56; 95% CI: 0.32-0.98; P = 0.0405). Population structure was evaluated using the structured association method using data from 161 ancestry-informative markers and did not affect our findings. We used an independent cohort of 34 AA and 160 CA in an attempt to validate our findings, although notable differences were found in the characteristics of the two patient groups. Although we observed a similar protective trend for the Mx1-CAGT haplotype in the validation set, the association was not statistically significant. Conclusion: In addition to other factors, polymorphisms in cytokine genes may play a role in the progression of HCV-related fibrosis; however, further studies are needed.

AB - Candidate genes, including myxovirus resistance-1 (Mx1), protein kinase (PKR), transforming growth factor-β1 (TGF-β), interleukin-10 (IL-10), and interferon-gamma (IFN-γ), were evaluated for associations with liver fibrosis in 374 treatment-naive patients with genotype-1 chronic HCV infection [194 Caucasian Americans (CAs) and 180 African Americans (AAs)], using a genetic haplotype approach. Among the 18 haplotypes that occurred with a frequency ≥5% in the cohort overall, the Mx1-(-123C)-(+6886A)-(+19820G(379V))-(+38645T) (abbreviated Mx1-CAGT), and PKR-(+110T)-(+7949G)-(+13846A)-(+22937Tj-(+40342T) (abbreviated PKR-TGATT) haplotypes were independently associated with less severe hepatic fibrosis (Ishak ≥ 3 versus s) = 0.6)], and race (for Mx1-CAGT: OR = 0.33; 95% CI: 0.16-0.68; P = 0.0027; and for PKR-TGATT: OR = 0.56; 95% CI: 0.32-0.98; P = 0.0405). Population structure was evaluated using the structured association method using data from 161 ancestry-informative markers and did not affect our findings. We used an independent cohort of 34 AA and 160 CA in an attempt to validate our findings, although notable differences were found in the characteristics of the two patient groups. Although we observed a similar protective trend for the Mx1-CAGT haplotype in the validation set, the association was not statistically significant. Conclusion: In addition to other factors, polymorphisms in cytokine genes may play a role in the progression of HCV-related fibrosis; however, further studies are needed.

UR - http://www.scopus.com/inward/record.url?scp=34547419223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547419223&partnerID=8YFLogxK

U2 - 10.1002/hep.21636

DO - 10.1002/hep.21636

M3 - Article

C2 - 17526009

AN - SCOPUS:34547419223

VL - 46

SP - 74

EP - 83

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 1

ER -